According to the GEO database (GSE12460) and clinical data, high expression of DUXAP8 is associated with advanced neuroblastoma, and DUXAP8 expression is negatively correlated with overall survival in neuroblastoma patients.260. Here, DUXAP8 is linked to neuroblastoma.